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Experimental Section 
Membrane protein extraction. Membrane proteins were extracted using a Mem-PER™ Plus Membrane 
Protein Extraction Reagent kit following the manufacturer’s protocol. Approximately 5 x 106 MCF-7 cells 
were harvested from the culture dish by incubating with TrypLE Express cell dissociation reagents for 5-
10 min and then centrifuged. The pellet was washed with 3 mL of the kit’s cell wash solution and the 
resultant solution centrifuged. The supernatant was removed and discarded, and the cell pellet was 
resuspended in 1.5 mL of a cell wash solution, transferred to a centrifuge tube, and centrifuged with the 
supernatant discarded. 750 μL of permeabilization buffer was added to the cell pellet and briefly vortexed 
to obtain a homogeneous solution. The pellet was then incubated at 4ºC for 10 min with constant mixing. 
After incubation, the cells were centrifuged at 16,000× g for 15 min with the supernatant discarded, which 
contained the cytosolic proteins. 500 μL of a solubilization buffer was added to the remaining cell pellet 
and the cells were resuspended and incubated at 4ºC for 30 min with constant mixing. Lastly, 
centrifugation was done at 16,000x g for 15 min and 4ºC. The remaining supernatant contained the 
solubilized membrane and membrane-associated proteins. 
Biotinylation of MCF-7 cells. In order to determine if MCF-7 cells were indeed biotinylated, we used 
FITC-conjugated avidin to visualize the cells that had been reacted with sulfo-NHS-SS-biotin. After 
biotinylation and removal of excess reagent, a 10 µL aliquot of a 100X diluted solution of FITC-avidin 
(1X in PBS) was added to 1 mL of the biotinylated cells (PBS) and incubated at room temperature 
(covered in aluminum foil) for 30 min. After incubation, the cells were washed thoroughly to remove 
excess FITC-avidin from the solution. The cells were then visualized using a Carl Zeiss Axiovert 200M 
inverted microscope coupled to a 75 W XBO lamp. The images of these cells are shown in Figure S1. As 
can be seen, the MCF-7 cells were fluorescent indicative of successful biotinylation.  
 
 
 
 
 
Figure S1. Fluorescence image taken at 488/520 nm 
excitation/emission (20x, 200 ms exposure time) of biotinylated 
MCF-7 cells that had been incubated with FITC-conjugated 
avidin. 20 μm 
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Experimental workflow. In addition to Scheme 1, Table S2 summarizes the experimental workflow for 
preparation of the µSPE device and isolation, purification, visualization, and quantification of the 
biotinylated membrane proteins as well as their removal from the extraction bed. 
Table S2. Summary of workflow for the µSPE of biotinylated membrane proteins. 
Assay Step Purpose Method 
Device activation 
To generate carboxylic acid functionalities for 
NeutrAvidin immobilization 
Irradiate PMMA micropillars (254 nm, 
22 mW/cm
2
) for 15 min 
NeutrAvidin 
immobilization 
EDC/NHS activates carboxylic acids on 
micropillar surfaces for NeutrAvidin 
immobilization 
EDC/NHS activation (30 min at room 
temperature) and infusion of 
NeutrAvidin and incubation overnight at 
4°C 
Membrane protein 
extraction 
Isolate biotinylated proteins via NeutrAvidin 
immobilized in μSPE bed 
Infuse cell lysate at constant flow rate  
Purification Remove cytosolic contaminants 
High salt (1 M KCl), high pH (11.5) 
wash 
Visualization 
Bind FITC-avidin to unbound biotins on the 
membrane proteins to visualize bound 
membrane proteins 
Infuse FITC-avidin solution; PBS wash 
to remove nonspecific FITC-avidin; 
visualize via fluorescence microscopy 
Elution of 
membrane proteins 
Reduce disulfide bond of biotin moiety and 
quantify release of protein 
Incubate with 300 mM DTT; analyze 
effluent (biotinylated membrane proteins 
and FITC-avidin) with fluorometer 
 
Results and Discussion 
Computation fluid dynamics (CFD) analysis of velocity fields, diffuse protein transport, and protein 
extraction in different µSPE bed configurations. For the CFD simulations, three model geometries 
composed of staggered rows of micropillars were tested (see Figure S2): (I) Circular pillars with 
diameters of 100 µm and pillar-to-pillar spacing of 50 µm; (II) diamond-shaped pillars with a side length 
of 20 µm (fileted by 5 µm to reflect the fabrication limits of micro-milling) and a pillar-to-pillar spacing 
of 20 µm; and (III) circular pillars with radii of 20 µm and a pillar-to-pillar spacing of 20 µm. In all 
geometries, the number of pillars was restricted to only a few staggered rows (relative to the hundreds 
occupying a single µSPE bed) to ensure numerical tractability of the simulations. 
Using these geometries, CFD simulations of steady-state laminar flow through the µSPE beds were 
evaluated using COMSOL Multiphysics to provide the velocity fields shown in Figure S2. For 
comparison, µSPE beds were designed within COMSOL to have the same fluidic inlet with the fluid 
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(modeled with the properties of water) entering the beds assigned a linear velocity of 0.83 mm s
-1
 to 
reflect a volumetric flow rate of 1 µL min
-1
. 
Throughout each bed, the flow velocity (and thereby reagent flux) was uniform, indicating that 
protein solutes uniformly infused through the µSPE bed and were distributed across the entirety of the 
µSPE’s surface area. However, these results do not reflect the effects of diffusion (i.e., diffusion of 
protein into adjacent flow streams that may be in proximity to the extraction surface) or how device 
geometry, such as micropillar shape or pillar-to-pillar spacing, encourages diffusion into these flow 
streams. For this, we conducted diffusion calculations in the subsequent section using average protein 
velocities through the µSPE bed geometries that were extracted from the velocity fields in Figure S2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Steady-state velocity profiles of µSPE 
bed geometries I-III. Flow fields are scaled in both 
size and magnitude. The solid-white arrows 
indicate the direction of flow.  
 
Diffusion model for approximating the effects of micropillar geometry on effective bed length and 
protein extraction. Only biotinylated proteins within a few nanometers of the µSPE bed’s surface may 
be extracted by the surface-confined NeutrAvidin molecules. Initial protein in these active flow lines are 
likely to be rapidly depleted; the protein molecules not resident within these flow lines must necessarily 
diffuse to the µSPE bed’s surface for extraction to take place, a phenomenon that occurs over a time 
proportional to the µSPE bed’s entire length (L = 24 mm) and the protein’s average velocity ( ).  
In general, the axial position of a protein in a fluidic channel (x) may be described as a Gaussian 
probability packet that spreads in time according to its diffusion coefficient (D) and an analytic solution to 
Fick’s second law:  
                    (   )  
 
√    
 
( 
  
   
)
                             (1) 
Electronic Supplementary Material (ESI) for Analyst
This journal is © The Royal Society of Chemistry 2014
5 
 
where P(x,t) is the probability that a protein occupies axial position x at time t according to a Gaussian 
packet with standard deviation   √    √      . 
If we consider a worst case scenario, where a protein has the initial position exactly centered between 
two pillars (   ) that have a pillar-to-pillar spacing of    (boundary conditions of      ), the 
probability that a protein has diffused to and interacted with the pillars (  ) during its transit through the 
µSPE bed is given by integration of the following equation: 
   (       ̅)   ∫  (         ̅
 
| |     
)         (2) 
A simple method of performing this integration uses z-scores associated with the Gaussian packet, 
where  ( )      and   ( ) is the normalized area of the Gaussian packet from    to  ( ). Thus, Eq. (2) 
can be simplified to: 
           (       ̅)    [  (    
 
)
  
 (   
  
 
)
]                (3) 
Eq. (3) can be solved with a standard Excel spreadsheet by calculating   √      ̅  and solving 
for  (   
 
 
) and    using the NORMSDIST function. Operations given by Eqs. (2) and (3) are 
illustrated in Figure S3 for convenience. 
Figure S3. Schematic 
for calculating the 
probability of a protein 
extracted by the µSPE 
beds’ micropillars (Pi) 
from the time-dependent 
Gaussian probability 
packets and the 
analytical solution to 
Fick’s 2nd law. 
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In Figure 5, we show the solutions for geometries I-III. Here, we used the average velocities through 
the µSPE beds for geometries I-III that were obtained via the simulation results shown in Figure S2 and 
scaled these velocities proportionally for higher and lower flow rates.  
It should be noted that a protein does not travel linearly through the bed; instead it will 
circumnavigate micropillars and travel an effective length,           , where C is a geometric 
correction factor intimately tied to the pillar shape. Thus, the fact that micropillars create obstacles, which 
fluid must flow around, increases the time for protein diffusion to occur as well as the probability of 
extraction. For circular pillars, the protein will travel about a half circumference yielding,       
    ; for diamond pillars, the protein travels about a triangle yielding,   √      . These assignments 
can be shown to be independent of the pillar size, which are geometrically illustrated in Figure 5 and can 
be represented by simply substituting      for   in Eqs. (2) and (3). Consequently, the effective path 
length of proteins traveling through µSPE beds with circular pillars is slightly longer than that of µSPE 
beds with diamond pillars due to the larger perimeter of (and path length of fluid around) circular 
micropillars permitting increased time for diffusion to occur and improved probability that proteins 
interact with the pillars and thus are recovered. 
We must note that this model is a simplification of actual diffusion effects in the µSPE beds. Average 
velocities extracted from the velocity fields in Figure S2 were applied to protein diffusion irrespective of 
the protein’s position in time. Realistically, as the protein diffuses away from the central     position, 
its velocity decreases according to Poiseuille flow, and the time scale available for diffusion would 
increase. Thus, there is some error in the absolute time scales over which diffusion occurs, and the results 
presented herein represent an underestimation of device efficiency. To correct this assumption, the 
average velocity term  ̅ in Eqs. (2) and (3) would be replaced with a position dependent velocity term, 
 ( ), but this would require a formulation within COMSOL itself because flow in the µSPE bed is not 
equivalent to a straight channel as can be seen in Figure S2; there is a large discrepancy between flow 
velocity between micropillars and in the areas between rows of micropillars.  
This model must be treated as a simplification of diffusion effects and the efficiency of protein 
extraction in the µSPE beds, and one should only take meaning in the relative impact of volumetric flow 
rate and micropillar shape and spacing on protein extraction efficiency rather than absolute efficiency 
itself. Thus, the results in Figure 5 indicate that future µSPE bed designs should incorporate circular 
micropillars with reduced pillar-to-pillar spacing (discussed further in the main text). 
 
 
Electronic Supplementary Material (ESI) for Analyst
This journal is © The Royal Society of Chemistry 2014
